Clinical Trial Update: Rivaroxaban in Mechanical Valves: RMV Study

View source ↗

Summary

The RMV study evaluating rivaroxaban in patients with mechanical heart valves is no longer available, indicating the trial has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prosthetic Heart Valve Disease

Drugs mentioned

• Rivaroxaban (rivaroxaban)

Snippet

Sponsor: Hospital Ana Nery | Conditions: Prosthesis; Cardiac, Heart, Functional Disturbance as Result | Status: NO_LONGER_AVAILABLE